$0.29 0.00 (+0.03%)
11/27/2009 12:59 PM

Aastrom Biosciences, Inc. (ASTM)

CAPS Rating: No stars

The regenerative medicine company engaged in clinical development of autologous cell products for the repair or regeneration of multiple human tissues, based on proprietary Tissue Repair Cell Technology.

Results 1 - 5 of 5

Recs

0
Member Avatar rtrieone (< 20) Submitted: 4/9/2007 9:08:39 PM : Outperform Start Price: $1.53 ASTM Score: -61.30



They will need time to get the studies done. This stuff works and very exciting to see it all come alive and make a lot of money investing....

Recs

0
Member Avatar scott627 (< 20) Submitted: 4/8/2007 7:10:02 PM : Outperform Start Price: $1.61 ASTM Score: -62.07

Using audlt stem cells may take the edge off the whole stem cell debate. They will need to push hard the "adult" angle to come out a winner.

Recs

0
Member Avatar wynharter (< 20) Submitted: 2/23/2007 1:35:31 PM : Outperform Start Price: $1.50 ASTM Score: -60.74

Their TRC's are non-invasive, personal blood stem cells, being proven a success in clinics and create no side affects. Also non-controversal and morally acceptable.

wyn harter

Recs

0
Member Avatar verncox (< 20) Submitted: 2/14/2007 11:46:06 PM : Outperform Start Price: $1.52 ASTM Score: -60.75

Flucuates between .50 and 5.00

Recs

0
Member Avatar EXOTHERMIC (86.32) Submitted: 1/8/2007 7:22:44 PM : Outperform Start Price: $1.64 ASTM Score: -64.62

legislation is pending improving funding to stem cell research companies, expect a gain in this market at least for the short term.

Results 1 - 5 of 5

Featured Broker Partners